These data raise the possibility that FoxP3+ T lymphocytes may preferentially suppress T-cell immune responses driven by microbial rather than tumor-associated antigens [11], and could account for their observed favorable prognostic impact in tumors rich in microbial pathogens, such as cancers of the colon and oral cavity [17], [42], [43]. This evidence concerns the gene FOXP3 and cancer.